Bone marrow aspirate

PreclinicalBiologic

WWashington University School of Medicine

Bone marrow aspirate is one of 22 biologic programs targeting Plantar Fasciitis. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Plantar FasciitisActive, not recruiting

KneeRecruiting

ConcentrationTerminated

Plantar FasciitisPreclinical

Active, not recruiting

KneePreclinical

Recruiting

ConcentrationPreclinical

Terminated

Competition

Competitive Landscape

17 competitors in Concentration

#DrugCompanyPhaseTrials

Vibativ

AApotex Inc.

Approved

1 2

Wilate

Octapharma

Phase 3

1 3

Xyrem

Jazz Pharmaceuticals

Preclinical

1 4

Inhaled Nitric Oxide

LLee's Pharmaceutical Limited

Phase 1

1 5

Isentress

CCidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Preclinical

3 6

Vfend

PPrism Pharmaceuticals

Preclinical

3 7

Zibotentan/dapagliflozin

AstraZeneca

Phase 1

1 8

Biological Data

UUniversity Hospital, Bordeaux

Preclinical

1 9

Blood Redrawal

CCentre Hospitalier Universitaire, Amiens

Preclinical

1 10

Lipopolysaccharide

Boehringer Ingelheim

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q1 2027

Phase 3Not yet recruiting

Osteoarthritis

NCT06238934

Q1 2028

N/ARecruiting

Plantar Fasciitis

NCT07242729

Q2 2030

PreclinicalRecruiting

Knee

NCT06893302

Clinical

Trials by Indication[1]

Osteoarthritis2 trials

BMA vs Cortisone for Glenohumeral Osteoarthritis

Completed·WWomen's College Hospital·Phase 2/3·NCT03580148·34 enrolled

Treatment of Knee Osteoarthritis With Bone Marrow Aspirate Matrix: Prospective, Randomized Trial

Not yet recruiting·IInstituto Nacional de Traumatologia e Ortopedia·Phase 3·NCT06238934·90 enrolled

Plantar Fasciitis1 trial

Bone Marrow Aspirate Versus Platelet-Rich Fibrin for the Treatment of Chronic Plantar Fasciitis

Recruiting·FFederal University of São Paulo·N/A·NCT07242729·72 enrolled

Concentration1 trial

Bone Marrow Aspirate Concentration in Posterior Cervical Fusion

Terminated·WWashington University School of Medicine·N/A·NCT02068547·8 enrolled

Chronic Wounds1 trial

Study to Evaluate Bone Marrow Cells in the Treatment of Chronic Wounds

Terminated·DDr. E.Badiavas·Phase 1·NCT02319720·11 enrolled

Granuloma1 trial

Treatment and Natural History Study of Lymphomatoid Granulomatosis

Completed·NNational Cancer Institute (NCI)·Phase 2·NCT00001379·94 enrolled

1 more indication

Knee1 trial

Bone Marrow Aspirate Injections in Knee Arthroscopy: A Randomized, Single-Blind, Controlled Trial

Recruiting·HHospital for Special Surgery, New York·Preclinical·NCT06893302·50 enrolled

Sources

References

[1]
ClinicalTrials.gov — 7 trial records for Bone marrow aspirate. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Bone marrow aspirate compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Bone marrow aspirate. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Washington University School of Medicine company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Biologic[2]
Highest Phase: Preclinical[1]
Company: WWashington University School of Medicine

Bone marrow aspirate

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q1 2027

Q1 2028

Q2 2030

Trials by Indication[1]

Osteoarthritis2 trials

Plantar Fasciitis1 trial

Concentration1 trial

Chronic Wounds1 trial

Granuloma1 trial

Knee1 trial

References

Drug Info

Quick Facts

Related News